Progress in the treatment of adolescents with acute lymphoblastic leukemia
โ Scribed by Gaston K. Rivera; Ching-Hon Pui; Victor M. Santana; Michael L. Hancock; Hazem Mahmoud; John T. Sandlund; Raul C. Ribeiro; Wayne Furman; Neyssa Marina; William M. Crist
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 587 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Thirty-seven adult patients with acute lymphoblastic leukemia were treated with a protocol called HEAV'D including Adriamycin, Vincristine, L-Asparaginase, Cyclophosphamide and Dexamethasone. The complete remission rate was 70 per cent. The median duration of remission was more than 30 months. Patie
## Abstract Significant progress in understanding the mechanisms leading to the development of acute myeloid leukemia (AML) has led to the identification of numerous molecular abnormalities that may be responsible for leukemogenesis. Over the same period, large trials have established standard regi
## Abstract A 3 1/2 year old girl with cystic fibrosis who underwent successful treatment for acute lymphoblastic leukemia remains in complete remission 36 months after diagnosis. We also report high clearance rates of three antineoplastic agents in this patient. Drug doses were adjusted to achieve